Login
Related Links
Advertise on this site?
Advertising opportunities on Gene Therapy Net include standard size banners as well as text ads. Click here for more information about advertising.
You can also make a donation by PayPal and support the Gene Therapy Net website.
Companies - E
| Enzo Biochem, Inc. Biotechnology company focused on the development of enabling technologies in the areas of gene regulation and gene modification. |
|
Information Companies
Overview of biotechnology companies involved in gene therapy and/or cell therapy, as well as contract research organizations (CRO) and medical supply companies.
The provided information about the companies is just a summary of the information giving on their websites and is therefore not always complete, correct and/or exhaustive. Please visit the companies websites for a complete picture of the company.
Your company not listed? Click here to submit.
Like to work for a company? Find here the perfect job in gene therapy.
Gene Therapy News
- Genethon’s Gene Therapy GNT0004 Continues to Show Potential in DMD - CGTLive™
Wed, 19 Mar 2025 23:56:5 GMT - Sarepta’s gene therapy faced internal FDA doubts. Now, a teen has died - Healthcare Brew
Wed, 19 Mar 2025 23:02:1 GMT - Gene Therapy Tested in Mice Offers New Hope for People with Dravet Syndrome - Genetic Engineering & Biotechnology News
Wed, 19 Mar 2025 22:25:1 GMT - Around the Helix: Cell and Gene Therapy Company Updates – March 19, 2025 - CGTLive™
Wed, 19 Mar 2025 22:22:3 GMT - Breakthrough gene therapy alleviates Dravet syndrome symptoms in mice without side effects - Medical Xpress
Wed, 19 Mar 2025 21:36:0 GMT - STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children - AJMC.com Managed Markets Network
Wed, 19 Mar 2025 21:06:2 GMT - Novartis reports positive Phase III results for SMA gene therapy OAV101 IT - The Pharma Letter
Wed, 19 Mar 2025 20:16:0 GMT - Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy - AOL
Wed, 19 Mar 2025 20:09:2 GMT - Regenxbio touts biomarker data for DMD gene therapy, but safety could be its winning argument - FirstWord Pharma
Wed, 19 Mar 2025 19:58:5 GMT - Gene Therapy Offers Hope for Dravet Syndrome Treatment - Technology Networks
Wed, 19 Mar 2025 19:04:2 GMT - Therapeutic potential of AAV2-shmTOR gene therapy in reducing retinal inflammation and preserving endothelial Integrity in age-related macular degeneration - Nature.com
Wed, 19 Mar 2025 18:16:2 GMT - Sarepta's gene therapy under scrutiny after patient death - Medical Xpress
Wed, 19 Mar 2025 18:00:0 GMT - Regenxbio Touts Positive Biomarker Data From Duchenne Muscular Dystrophy Gene Therapy Trial - Benzinga
Wed, 19 Mar 2025 17:38:5 GMT - Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise in OPMD - Investing.com
Wed, 19 Mar 2025 17:20:1 GMT - Regenxbio shares new Duchenne gene therapy data ahead of big readout next year - Endpoints News
Wed, 19 Mar 2025 16:14:0 GMT